Givaudan SA Stock (CH0010645932): Consensus Hold Rating from Seven Brokerages

Givaudan SA (OTCMKTS:GVDNY) has received a consensus 'Hold' rating from seven brokerages, with two sells, three holds, and two buys. The stock opened at $71.82, below its 200-day moving average of $78.57.

Givaudan SA (OTCMKTS:GVDNY) shares have received a consensus recommendation of "Hold" from seven ratings firms covering the company, according to MarketBeat, April 25, 2026. The breakdown includes two sell ratings, three hold ratings, and two buy ratings. This mixed sentiment reflects recent analyst actions, including a buy reiteration from Deutsche Bank and downgrades to hold from Barclays and Berenberg, alongside a sell cut from Goldman Sachs.

As of: April 30, 2026

By the AD HOC NEWS Editorial Team – Equity Coverage.

At a Glance

• Name: Givaudan
• ISIN: CH0010645932
• Sector/Industry: Materials/Chemicals - Specialty
• Headquarters/Country: Vernier, Switzerland
• Primary Exchange: SIX Swiss Exchange (GIVN.SW), OTC (GVDNY)
• Trading Currency: CHF (primary), USD (OTC) with FX risk

How Givaudan SA Makes Money: The Core Business Model

Givaudan SA develops, manufactures, and sells olfactory and taste products for consumer goods industries worldwide. The company operates through two main segments: Taste & Wellbeing and Fragrances, according to its investor information on the official website. It supplies flavors and fragrances to food, beverage, and personal care companies.

Spun off from Roche in 2000, Givaudan has built a global presence in more than 80 countries, focusing on innovation in flavor and fragrance creation. The business model emphasizes research and development to create sensory solutions for major brands in perfumes, cosmetics, and food products.

Value creation for shareholders occurs through dividend payments, share repurchase programs, and share price appreciation since the 2000 spin-off, as stated in investor materials from Givaudan.com investor information.

Givaudan SA's Key Revenue and Product Drivers

Givaudan generates revenue primarily from its Taste & Wellbeing division, which includes sweet, savory, and beverage flavors, and the Fragrance division covering fine fragrances, consumer products, and health & nutrition. These segments drive sales through custom solutions for global brands in food, beverages, and personal care.

The company invests heavily in R&D to innovate in natural extracts and sustainable ingredients, supporting growth in clean-label products. Herb and spice extracts represent a key area, with Givaudan noted among leading contributors in market outlooks.

Recent stock performance shows Givaudan opening at $71.82 on the OTCMKTS:GVDNY, within a 52-week range of $65.97 to $103.39, per MarketBeat, April 25, 2026.

Industry Trends and Competitive Landscape

The flavor and fragrance industry faces trends toward sustainable sourcing, clean-label positioning, and strengthening global distribution networks. Key players include Givaudan, Kerry Group, McCormick & Company, Sensient Technologies, and Symrise, according to a PR Newswire market outlook to 2036.

Givaudan competes in a concentrated market where innovation in natural flavors and regulatory compliance drive competitive edges. Peers like Symrise and International Flavors & Fragrances (IFF) operate in identical segments, verifiable via their annual reports.

Demand for herb and spice extracts grows with consumer preference for natural ingredients, positioning Givaudan favorably in long-term industry expansion.

Why Givaudan SA Matters to US Investors

Givaudan SA trades on US OTC markets as GVDNY, providing US investors access to this Swiss flavor leader without direct SIX Swiss Exchange exposure. The OTC listing facilitates trading in USD, though with inherent CHF-USD FX risk.

US investors follow Givaudan for its role in supplying major American consumer brands in food and personal care, contributing to portfolios diversified in specialty chemicals. Recent consensus ratings from brokerages are tracked by US platforms like MarketBeat.

The company's global revenue includes significant exposure to North American markets, making it relevant for US equity coverage amid industry trends in sustainable ingredients.

Which Investor Profile Fits Givaudan SA – and Which Does Not?

Investors interested in stable consumer staples with defensive qualities may track Givaudan due to its essential role in everyday products like flavors and fragrances. Those focused on innovation-driven growth in health and nutrition segments find alignment with its R&D emphasis.

High-growth tech seekers or cyclical commodity plays may not suit, given the mature nature of the flavor industry. Profiles avoiding FX risk or preferring US-domiciled firms might look elsewhere, despite OTC availability.

Long-term holders prioritizing dividend growth since 2000 match the shareholder return model outlined in company materials.

What Analysts Are Saying About Givaudan SA Stock

Seven brokerages maintain coverage on Givaudan SA, resulting in a Hold consensus as of April 25, 2026. Recent actions include Deutsche Bank reiterating Buy, Goldman Sachs cutting to Sell, and Barclays and Berenberg moving to Hold, per MarketBeat data.

Citigroup reissued Neutral on February 3, 2026, contributing to the mixed outlook. Coverage reflects balanced views on valuation and growth prospects in flavors and fragrances.

Risks and Open Questions for Givaudan SA

Currency fluctuations between CHF and USD pose risks for US investors trading GVDNY, amplified by Switzerland's economic conditions. Commodity costs for raw ingredients in flavors could pressure margins amid supply chain disruptions.

Regulatory scrutiny on synthetic vs. natural ingredients evolves, potentially impacting product portfolios. Competitive intensity from peers like Symrise requires sustained R&D investment.

Subdued price momentum, with shares below the 200-day moving average, raises questions on near-term catalysts, as noted in recent brokerage coverage.

Key Events and Outlook for Investors

Givaudan continues share repurchases and dividend growth as part of its shareholder return policy, per investor information. Monitoring upcoming analyst updates and industry reports on sustainable extracts provides forward visibility.

Quarterly results and capital markets events offer milestones, though specific dates require IR confirmation.

What to Watch Next

• Analyst Updates: Potential rating changes post-consensus
• IR Releases: Dividend and buyback announcements

Conclusion

The Hold consensus from seven brokerages underscores mixed analyst views on Givaudan SA as of April 25, 2026. With shares trading at $71.82 below key averages, focus remains on flavor industry trends and shareholder returns. US investors monitor OTC performance amid global operations.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.